A recent addition to Pubmed citations from J ECT is this literature review of the incidence of headache after ECT, from Dutch investigators:
The Incidence of Post-Electroconvulsive Therapy Headache: A Systematic Review
J ECT 2020 Mar 20[Online ahead of print] PMID: 32205737
The pdf is here.
The results show that about a third of patients experience headache after ECT, and that, overall, it occurs in about one in ten ECT sessions.
The article really focuses on incidence of headache, not etiology nor treatment.
Our goal as ECT practitioners is to make ECT as safe and comfortable as possible for patients; to that end, treatment of post-ECT headache is an important feature of good ECT practice. Typically, simple analgesics are effective. A common treatment strategy to prevent headache (in patients who have previously experienced it) is pre-procedural administration of 15-30 mg intravenous ketorolac (Toradol).
The results show that about a third of patients experience headache after ECT, and that, overall, it occurs in about one in ten ECT sessions.
The article really focuses on incidence of headache, not etiology nor treatment.
Our goal as ECT practitioners is to make ECT as safe and comfortable as possible for patients; to that end, treatment of post-ECT headache is an important feature of good ECT practice. Typically, simple analgesics are effective. A common treatment strategy to prevent headache (in patients who have previously experienced it) is pre-procedural administration of 15-30 mg intravenous ketorolac (Toradol).
Comments
Post a Comment